Abstract
When investing in emerging market investors face issues regarding the valuation of potential investment that may affect the investment decision considerably. This article discusses the challenges of valuing a company in European emerging markets. We will focus on several issues regarding the reliability and fitness of the estimated Betas on cross-border investment valuation.